← Leaderboards
Stephen John Lewis
University Of Florida
$6,923,832
Attributed
$8,069,898
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,744,249 · 15
By mechanism
P01$8,674,351 · 1
OT2$2,612,940 · 1
U01$1,450,583 · 1
R01$1,210,673 · 1
R61$1,136,617 · 1
U18$598,165 · 1
Top collaborators
- Benjamin M Gaston9 shared
- Lisa A Palmer6 shared
- Dominique M Durand4 shared
Others in their field
Top investigators on “Rattus”
- Barney Sparrow · Battelle Memorial Institute$76,162,078
- Reshan Fernando · Research Triangle Institute$42,714,061
- Boris Tabakoff · University Of Colorado Denver$35,561,072
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$35,063,410
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$34,625,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Research focus
RattusCellsBreathingSignal TransductionPreventPlayGlossopharyngealNerveHypertensionBlood PressureNovel TherapeuticsCysteineStructureCarotid BodyProteinsRegulationMechanicsDesignPathway InteractionsPeripheralIn VitroAffectLungTissues
Grant awards (33)
Repurposing L-NAC to prevent fentanyl-induced respiratory depression$201,250
R21 · FY2024 · DA · contact PI
Repurposing L-NAC to prevent fentanyl-induced respiratory depression$241,500
R21 · FY2023 · DA · contact PI
Sudaxine as an analgesia sparing respiratory stimulant for use in critical care$557,350
R33 · FY2022 · HL
Optimization of novel thioesters as a therapeutic strategy for combating opioid overdoses and abuse$478,257
U01 · FY2022 · DA · contact PI
Sudaxine as an analgesia sparing respiratory stimulant for use in critical care$560,996
R61 · FY2021 · HL
Optimization of novel thioesters as a therapeutic strategy for combating opioid overdoses and abuse$478,257
U01 · FY2021 · DA · contact PI
Sudaxine as an analgesia sparing respiratory stimulant for use in critical care$575,621
R61 · FY2020 · HL
Optimization of novel thioesters as a therapeutic strategy for combating opioid overdoses and abuse$494,069
U01 · FY2020 · DA · contact PI
Functional Mapping of the afferent and Efferent Projections of the Superior Cervical Ganglion Interactome$223,450
OT2 · FY2019 · OD · contact PI
Functional Mapping of the afferent and Efferent Projections of the Superior Cervical Ganglion Interactome$951,218
OT2 · FY2018 · OD · contact PI
Functional Mapping of the afferent and Efferent Projections of the Superior Cervical Ganglion Interactome$613,428
OT2 · FY2017 · OD · contact PI
Novel nanowire interface with the autonomic nervous system to study hypertension$64,831
U18 · FY2017 · EB
Functional Mapping of the afferent and Efferent Projections of the Superior Cervical Ganglion Interactome$824,844
OT2 · FY2016 · OD · contact PI
Novel nanowire interface with the autonomic nervous system to study hypertension$247,434
U18 · FY2016 · EB
Novel nanowire interface with the autonomic nervous system to study hypertension$38,166
U18 · FY2016 · EB
Cellular S-nitrosothiol signaling in respiratory biology$1,750,447
P01 · FY2015 · HL
Novel nanowire interface with the autonomic nervous system to study hypertension$247,734
U18 · FY2015 · EB
Cellular S-nitrosothiol signaling in respiratory biology$1,731,785
P01 · FY2014 · HL
Cellular S-nitrosothiol signaling in respiratory biology$1,672,907
P01 · FY2013 · HL
Cellular S-nitrosothiol signaling in respiratory biology$1,062,860
P01 · FY2012 · HL
Cellular S-nitrosothiol signaling in respiratory biology$656,462
P01 · FY2012 · HL
"Cellular S-nitrosothiol signaling in respiratory biology"$1,799,890
P01 · FY2011 · HL
Vagal afferent cell bodies as sensors of blood-borne factors$292,030
R01 · FY2010 · NS · contact PI
Vagal afferent cell bodies as sensors of blood-borne factors$295,075
R01 · FY2009 · NS · contact PI
Vagal afferent cell bodies as sensors of blood-borne factors$295,168
R01 · FY2008 · NS · contact PI
BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE$7,967
M01 · FY2008 · RR · contact PI
Vagal afferent cell bodies as sensors of blood-borne factors$328,400
R01 · FY2007 · NS · contact PI
ADVANCED NEUROMONITORING, AND BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURY$2,090
M01 · FY2007 · RR · contact PI
ADVANCED NEUROMONITORING, AND BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURY$16,240
M01 · FY2006 · RR · contact PI
BIOMARKERS OF BRAIN PATHOLOGY IN ADULT PATIENTS WITH TRAUMATIC BRAIN INJURY$13,434
M01 · FY2006 · RR · contact PI
BIOMARKERS OF BRAIN PATHOLOGY IN CHILDREN WITH TRAUMATIC BRAIN INJURY$9,903
M01 · FY2006 · RR · contact PI
ADVANCED NEUROMONITORING, AND BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURY$616
M01 · FY2005 · RR
Biomarkers of Brain Pathology in Adult Patients with Traumatic Brain Injury$10,570
M01 · FY2004 · RR